Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2020 | Outlook on the current CAR-T climate

Marcos de Lima • 27 Aug 2020
SOHO 2020
General CAR-T

Marcos de Lima, MD, UH Cleveland Medical Center, Cleveland, OH, provides an outlook on the current CAR T-cell climate including expanding the reach of therapies, determining the best model for manufacturing, and the goal of off-the-shelf therapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Marcos de Lima

1:08
Point-of-care CAR T-cells
Marcos de Lima • 26 Aug 2020
3:36
Results of a site-manufactured anti-CD19 CAR-T in nHL
Marcos de Lima • 31 Aug 2020
5:15
Outlook on the current CAR-T climate
Marcos de Lima • 1 Sep 2020
1:56
Are hypomethylating agents useful in preventing relapse in AML and MDS?
Marcos de Lima • 26 Oct 2019

Related Videos

1:08
Chronological age no longer dictates eligibility for allogeneic transplantation in patients with MDS
Didier Blaise • 4 Apr 2024
1:24
The future of CAR T-reg cells: organ transplantation & autoimmune disease
Zinaida Good • 9 Apr 2024
2:44
Do biomarkers exist for predicting response to CAR T-cell therapy?
Marco Ruella • 9 Apr 2024
2:43
Resistance to CAR T-cell therapy
Marco Ruella • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals